CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$1.10
+0.02 (+1.85%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,879.1% upside
Low Target
$14.42
Average Target
$21.77
High Target
$30.48
Current Price
$1.10
Current
$1.10
$1.10
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Scenario Analysis
Bear Case
$14.42
1,210.9%
Low target
Base Case
$21.77
+1,879.1%
Avg target
Bull Case
$30.48
+2,670.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$24.43
-95.5% from high
52-Week Low
$14.23
+-92.3% from low
Target vs 52W High
$21.77
-10.9% vs high
Next Earnings Report
Mar 2, 2026
14d
until earnings
Earnings in 14 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |